Q3 2026 13F · SEC CIK 315054
Regents of the University of California
Endowment & foundationFiled 2026-10-26 for Q3 2026. Open the filing ↗ · All SEC filings ↗
- Reported 13F value
- $6.6B
- Reported positions
- 11
- Top holdings a year, 3 yrs
- +27.9%
- Average holding period
- 3 qtrs
Regents of the University of California is an endowment & foundation that reported 11 positions worth $6.6B in its Q3 2026 13F, filed 2026-10-26. Its largest holdings were State Street Spdr Uc Investmen (UCBG, 37.6%), State Str Corp (STT, 26.0%), Space Exploration Techn Corp (SPCX, 14.1%). A portfolio copying its top holdings returned 27.9% a year over the last 3 years, against 20.4% for the S&P 500.
Regents of the University of California holdings all 11 positions.
Weights are shares of the filer's total reported 13F value, compared with Q2 2026. Share changes may reflect splits; weight changes also reflect price moves. A 13F shows long US-listed positions only, up to 135 days after the fact.
| Stock | % of 13F value | Share change | Reported value |
|---|---|---|---|
| UCBGState Street Spdr Uc Investmen | 37.6% | — | $2.5B |
| STTState Str Corp | 26.0% | -0.4% | $1.7B |
| SPCXSpace Exploration Techn Corp | 14.1% | +3.2% | $933.7M |
| ASMLAsml Hldg NV | 9.6% | +0.0% | $636.4M |
| OTFBlue Owl Technology Finance | 5.7% | -10.9% | $381.2M |
| BNBrookfield Corp | 4.9% | +0.0% | $327.4M |
| GLDMWorld Gold Tr | 1.8% | +0.0% | $118.2M |
| BBOTBridgebio Oncology Therapeut | 0.2% | — | $10.3M |
| EIKNEikon Therapeutics Inc | 0.1% | — | $5.1M |
| SRZNSurrozen Inc | 0.1% | +0.0% | $4.3M |
| OWLBlue Owl Capital Inc | 0.0% | -0.0% | $603K |
What Regents of the University of California bought and sold in Q3 2026, against Q2 2026.
New positions
- UCBG State Street Spdr Uc Investmen37.6% of 13F
- BBOT Bridgebio Oncology Therapeut0.2% of 13F
- EIKN Eikon Therapeutics Inc0.1% of 13F
Added to
No position grew by more than 5%.
Reduced
- OTF Blue Owl Technology Finance-10.9% shares
Sold out
- BLLN Billiontoone Incwas 0.1%
- CHYM Chime Financial Incwas 0.0%
- SRZNW Surrozen Incwas 0.0%
Share counts compared with the Q2 2026 13F; a split also changes share counts.
How the holdings did against the S&P 500.
- 1 year
- +44.8% /yr
- S&P 500 +20.1%
- 3 years
- +27.9% /yr
- S&P 500 +20.4%
- 5 years
- +9.2% /yr
- S&P 500 +11.6%
A portfolio of the filer's 20 largest 13F positions, weighted by value, bought the trading day after each 13F was filed and held until the next one was: what copying this filer could have earned. 13Fs show long US-listed positions only, so this is an estimate of the stock picks, not the fund's reported returns.
Reported 13F value by quarter.
| Quarter | 13F value | Positions |
|---|---|---|
| Q3 2026 | $6.6B | 11 |
| Q2 2026 | $4.4B | 11 |
| Q1 2026 | $3.0B | 12 |
| Q4 2025 | $2.2B | 9 |
| Q3 2025 | $1.3B | 7 |
| Q2 2025 | $514.9M | 5 |
| Q1 2025 | $468.4M | 7 |
| Q4 2024 | $322.8M | 5 |
| Q2 2024 | $182.9M | 7 |
| Q1 2024 | $344.0M | 26 |
| Q4 2023 | $796.3M | 27 |
| Q3 2023 | $779.0M | 28 |
Questions about Regents of the University of California's portfolio
What stocks does Regents of the University of California own?
Regents of the University of California's latest 13F, for Q3 2026 and filed Oct 26, 2026, lists 11 positions worth $6.6B. The largest are State Street Spdr Uc Investmen (UCBG) at 37.6%, State Str Corp (STT) at 26.0%, Space Exploration Techn Corp (SPCX) at 14.1%, Asml Hldg NV (ASML) at 9.6% and Blue Owl Technology Finance (OTF) at 5.7%.
What did Regents of the University of California buy last quarter?
In Q3 2026, Regents of the University of California added a new position in State Street Spdr Uc Investmen (UCBG), a new position in Bridgebio Oncology Therapeut (BBOT) and a new position in Eikon Therapeutics Inc (EIKN), compared with its Q2 2026 filing.
What did Regents of the University of California sell last quarter?
In Q3 2026, Regents of the University of California sold all of Billiontoone Inc (BLLN), sold all of Chime Financial Inc (CHYM), sold all of Surrozen Inc (SRZNW) and Blue Owl Technology Finance (OTF) (-10.9% shares), compared with its Q2 2026 filing.
How has Regents of the University of California's portfolio performed?
A portfolio copying Regents of the University of California's 20 largest 13F holdings each quarter, from the day each filing was public, returned +27.9% a year over the last 3 years, against +20.4% for the S&P 500. Over 1 year: +44.8% against +20.1%. Over 5 years: +9.2% a year against +11.6%.
When is Regents of the University of California's next 13F filing due?
13F filings are due 45 days after each quarter ends. Regents of the University of California's filing for the quarter ending Dec 31, 2026 is due by Feb 14, 2027; this page updates the day after it is published.